Endomorphin-induced motivational effect: differential mechanism of endomorphin-1 and endomorphin-2.

M. Narita, S. Ozaki, Tsutomu Suzuki
{"title":"Endomorphin-induced motivational effect: differential mechanism of endomorphin-1 and endomorphin-2.","authors":"M. Narita, S. Ozaki, Tsutomu Suzuki","doi":"10.1254/JJP.89.224","DOIUrl":null,"url":null,"abstract":"The newly discovered endogenous mu-opioid receptor (MOP-R) ligands endomorphin-1 (EM-1) and -2 (EM-2) exhibit the highest specificity and affinity for the MOP-R of any endogenous substance so far described in the mammalian nervous system. This review focuses on differential mechanism of the motivational effects induced by EM-1 and EM-2. In the [35S]GTPgammaS binding assay, either EM-1 or EM-2 causes a concentration-dependent G-protein activation in brain membrane of normal mice, whereas neither EM-1 nor EM-2 produces any activation of G-protein in membranes obtained from the MOP-R knockout mice. These results provide direct evidence at the molecular level that both EMs act on the MOP-R as the endogenous MOP-R agonists. Based on the conditioned place preference paradigm in mice, EM-1 given intracerebroventriculally produced a dose-related place preference. This effect was abolished by pretreatment with the MOP-R antagonist beta-funaltrexamine (FNA) but not the delta-opioid receptor (DOP-R) antagonist naltrindole and the kappa-opioid receptor (KOP-R) antagonist nor-bialtorphimine (BNI). Unlike EM-1, EM-2 exhibited a place aversion. The aversive effect was inhibited by not only beta-FNA but also nor-BNI. Place aversion produced by EM-2 was also attenuated by pretreatment with an antiserum against an endogenous KOP-R ligand dynorphin A(1-17). These findings indicate that EM-1 may produce its rewarding effect via MOP-Rs. Furthermore, the aversive effect induced by EM-2 may be associated with the stimulation of the EM-1-insensitive MOP-R subtype and necessarily activate an endogenous KOPergic system in the mouse brain.","PeriodicalId":14750,"journal":{"name":"Japanese journal of pharmacology","volume":"30 1","pages":"224-8"},"PeriodicalIF":0.0000,"publicationDate":"2002-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"12","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese journal of pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1254/JJP.89.224","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 12

Abstract

The newly discovered endogenous mu-opioid receptor (MOP-R) ligands endomorphin-1 (EM-1) and -2 (EM-2) exhibit the highest specificity and affinity for the MOP-R of any endogenous substance so far described in the mammalian nervous system. This review focuses on differential mechanism of the motivational effects induced by EM-1 and EM-2. In the [35S]GTPgammaS binding assay, either EM-1 or EM-2 causes a concentration-dependent G-protein activation in brain membrane of normal mice, whereas neither EM-1 nor EM-2 produces any activation of G-protein in membranes obtained from the MOP-R knockout mice. These results provide direct evidence at the molecular level that both EMs act on the MOP-R as the endogenous MOP-R agonists. Based on the conditioned place preference paradigm in mice, EM-1 given intracerebroventriculally produced a dose-related place preference. This effect was abolished by pretreatment with the MOP-R antagonist beta-funaltrexamine (FNA) but not the delta-opioid receptor (DOP-R) antagonist naltrindole and the kappa-opioid receptor (KOP-R) antagonist nor-bialtorphimine (BNI). Unlike EM-1, EM-2 exhibited a place aversion. The aversive effect was inhibited by not only beta-FNA but also nor-BNI. Place aversion produced by EM-2 was also attenuated by pretreatment with an antiserum against an endogenous KOP-R ligand dynorphin A(1-17). These findings indicate that EM-1 may produce its rewarding effect via MOP-Rs. Furthermore, the aversive effect induced by EM-2 may be associated with the stimulation of the EM-1-insensitive MOP-R subtype and necessarily activate an endogenous KOPergic system in the mouse brain.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
内啡肽诱导的动机效应:内啡肽-1和内啡肽-2的差异机制。
新发现的内源性mu-阿片受体(MOP-R)配体内啡肽-1 (EM-1)和-2 (EM-2)在哺乳动物神经系统中对MOP-R表现出最高的特异性和亲和力。本文就EM-1和EM-2诱导动机效应的差异机制作一综述。在[35S]GTPgammaS结合实验中,EM-1或EM-2在正常小鼠的脑膜中引起浓度依赖性的g蛋白激活,而EM-1和EM-2在MOP-R敲除小鼠的脑膜中都没有产生任何g蛋白激活。这些结果在分子水平上提供了直接证据,证明这两种EMs都是内源性的mopp - r激动剂作用于mopr。基于小鼠的条件位置偏好范式,EM-1在脑室内产生了剂量相关的位置偏好。用mopp - r拮抗剂-富纳曲胺(FNA)预处理可以消除这种作用,但用δ -阿片受体(dopr)拮抗剂纳曲多和κ -阿片受体(KOP-R)拮抗剂-双阿尔托啡胺(BNI)预处理则不能消除这种作用。与EM-1不同,EM-2表现出地方厌恶。β - fna和非bni均能抑制其不良反应。EM-2产生的地方厌恶也可以通过内源性kopp - r配体dynorphin A的抗血清预处理而减弱(1-17)。这些发现表明,EM-1可能通过mop - r产生其奖励作用。此外,EM-2诱导的厌恶效应可能与em -1不敏感的MOP-R亚型的刺激有关,并必然激活小鼠大脑中的内源性koperic系统。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Multidisciplinary Treatment for Conversion Disorder in an 8 Year Old Girl Treatment of the Mentally Ill in the Pre-Moral and Moral Era: A Brief Report A Case of Zolpidem-induced Hepatic Encephalopathy in a Patient with Major Depression Ten Year Follow Up of a Psychiatry Residency Program Merger Resident Teaching Expectations and Medical Student Feedback
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1